title: Corpus callosum: a favorable target for rSFV-mediated gene transfer to rat brain with broad and efficient expression.
abstract: Recombinant Semliki Forest virus (rSFV), as a new kind of neurotropic vector system, has great potential of gene therapy for stroke. However, very little is known about its transduction characteristics in cerebral cortex or corpus callosum (CC) in vivo, which are common targets for gene transfer in experimental stroke therapy. Here, we investigate and compare rSFV-mediated gene expression at above two brain regions in rat; 2.0 x 10(7) IU of rSFV encoding green fluorescent protein (rSFV-GFP) was locally injected into CC or cerebral cortex in two groups. At 36 h following injection, the number of GFP-positive cells, GFP distribution volume, and GFP expression level were examined in the rat brain of each group using continuous frozen sections and enzyme-linked immunosorbent assay. rSFV vector displayed noticeably different transduction patterns in CC and cerebral cortex in vivo. CC injection of vector increased GFP-positive cell number by 802%, GFP transduction volume by 958%, and GFP expression level by 508% compared with cortical injection (all P < 0.01). We concluded that rSFV CC delivery significantly enhances transduction efficiency in rat brain with its ability to achieve transgene extensive transduction and abundant expression, and CC may be a favorable target for improving rSFV-based gene delivery efficiency to brain.
authors.affiliation: Department of Neurosurgery, the Affiliated Hospital of Medical College, Qingdao University, Qingdao 266003, China.
authors.forename: Zhao-Jian
authors.initials: ZJ
authors.lastname: Li
authors.forename: Peng
authors.initials: P
authors.lastname: Sun
authors.forename: Hong-Di
authors.initials: HD
authors.lastname: Zhang
authors.forename: Shi-Fang
authors.initials: SF
authors.lastname: Li
authors.forename: Xia
authors.initials: X
authors.lastname: Liu
authors.forename: Ren-Zhi
authors.initials: RZ
authors.lastname: Wang
mesh_terms: D000818:Animals; D002545:Brain Ischemia / Q000235:genetics / Q000628:therapy*; D002540:Cerebral Cortex / Q000502:physiology; D003337:Corpus Callosum / Q000502:physiology*; D005786:Gene Expression Regulation / Q000502:physiology*; D015316:Genetic Therapy / Q000379:methods*; D049452:Green Fluorescent Proteins / Q000235:genetics; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D011994:Recombinant Proteins / Q000235:genetics; D012672:Semliki forest virus / Q000235:genetics*; D014161:Transduction, Genetic / Q000379:methods*
chemical_list: D011994:Recombinant Proteins; D049452:Green Fluorescent Proteins
references.citation: Gene Ther. 2005 Oct;12 Suppl 1:S92-7
references.pmid: 16231060
references.citation: Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):7041-6
references.pmid: 10359835
references.citation: J Neurosci Methods. 2004 Aug 15;137(1):111-21
references.pmid: 15196833
references.citation: Exp Brain Res. 2005 Mar;161(3):335-42
references.pmid: 15502982
references.citation: Neuropathol Appl Neurobiol. 2006 Aug;32(4):397-409
references.pmid: 16866985
references.citation: Gene Ther. 2000 Aug;7(15):1304-11
references.pmid: 10918501
references.citation: Mol Ther. 2005 Feb;11(2):327-31
references.pmid: 15668145
references.citation: J Mol Cell Cardiol. 2004 Jul;37(1):137-42
references.pmid: 15242744
references.citation: J Gen Virol. 1990 Nov;71 ( Pt 11):2575-83
references.pmid: 2174955
references.citation: Biochem Biophys Res Commun. 2007 Apr 13;355(3):776-81
references.pmid: 17316567
references.citation: Plant Cell Rep. 2003 Sep;22(2):117-21
references.pmid: 12845471
references.citation: Gene Ther. 2000 Mar;7(6):472-80
references.pmid: 10757020
references.citation: Exp Neurol. 2000 Dec;166(2):266-75
references.pmid: 11085892
references.citation: Mol Cell Neurosci. 2001 May;17(5):855-71
references.pmid: 11358483
references.citation: FEBS Lett. 2001 Aug 31;504(3):99-103
references.pmid: 11532440
references.citation: Stem Cells. 2007 Jan;25(1):98-106
references.pmid: 16960128
references.citation: J Neurovirol. 2003 Feb;9(1):1-15
references.pmid: 12587064
references.citation: Brain Res. 2006 Nov 29;1122(1):1-9
references.pmid: 17045577
references.citation: Hum Gene Ther. 2006 Mar;17(3):291-302
references.pmid: 16544978
references.citation: Mol Ther. 2003 Feb;7(2):202-9
references.pmid: 12597908
references.citation: Gene Ther. 2005 Oct;12 Suppl 1:S111-7
references.pmid: 16231043
references.citation: Curr Gene Ther. 2001 May;1(1):19-29
references.pmid: 12109136
references.citation: Methods. 2002 Oct;28(2):286-92
references.pmid: 12413428
references.citation: J Neurosci Res. 1993 Jul 1;35(4):445-51
references.pmid: 8360951